JC
JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
$3.33 +0.00% (+$0.00)
Market Cap ¥63.9B
P/E Ratio 73.87x
Div. Yield 3.92%
ROE 2.53%
Bulios Fair Price
$2.12
36.3% downside
Trenutna cena
$3.33
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica JCRRF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
30 /100
Expensive EV/EBITDA 25.85x
P/S 1.54x
P/B 1.49x
Growth
3 /100
Declining Book val. growth 2.58%
Rev. growth 13.49%
FCF growth N/A
Profitability
26 /100
Weak Net margin 2.08%
Op. margin 2.33%
FCF margin 0.00%
Quality
10 /100
Poor ROE 2.53%
ROA 0.82%
Asset turnover 0.39x
Debt
29 /100
High Current ratio 1.09x
Int. coverage 3.84x
Net debt/EBITDA 10.53x
Stability
30 /100
Unstable Rev. volatility 30.80%
EPS volatility 116.43%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JCRRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Toru Ashida
Employees
985
Headquarters
Ashiya
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
28 OKT.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila